Skip to main content
Log in

The significance of inflammation and regression in melanoma

  • Editorial
  • Published:
Virchows Archiv A Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Blessing K, McLaren KM, McLean A, Davidson P (1990) Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis. Histopathology 17:389–395

    CAS  PubMed  Google Scholar 

  • Bröcker E-B, Macher E, Sorg C (1990) Changes in the tumour-associated inflammatory infiltrates in the course of local and systemic progression of cutaneous melanoma. In: Ferrone S (ed) Human melanoma. Springer, Berlin Heidelberg New York, pp 278–293

    Google Scholar 

  • Clark WH, Elder DE, Dupont G, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC (1989) Model predicting survival in Stage 1 melanoma based on tumour progression. J Natl Cancer Inst 81:1893–1904

    PubMed  Google Scholar 

  • Cooper PH, Wanebo HJ, Ward Hagar R (1985) Regression in thin malignant melanoma. Arch Dermatol 121:1127–1131

    CAS  PubMed  Google Scholar 

  • Day CL, Mihm MC, Lew RA, et al. (1982) Prognostic factors for patients with clinical stage 1 melanoma of intermediate thickness (1.51–3.99 mm). Ann Surg 195:35–43

    PubMed  Google Scholar 

  • Drzewiecki KT, Andersen PK (1982) Survival with malignant melanoma. A regression analysis of prognostic factors. Cancer 49:2414–2419

    CAS  PubMed  Google Scholar 

  • Gromet MA, Epstein WL, Blois MS (1978) The regressing thin malignant melanoma. A distinctive lesion with metastatic potential. Cancer 42:2282–2292

    CAS  PubMed  Google Scholar 

  • Johnson JP, Stade BG, Rothbächer U, Lehmann JM, Riethmüller G (1990) Melanoma antigens and their association with malignant transformation and tumour progression. In: Ferrone S (ed) Human melanoma. Springer, Berlin Heidelberg New York, pp 106–118

    Google Scholar 

  • Kelly JW, Sagebiel RW, Blois MS (1985) Regression in malignant melanoma. A histologic feature without independent prognostic significance. Cancer 56:2287–2291

    CAS  PubMed  Google Scholar 

  • Kopf AW, Welkovich B, Frankel RE, Stoppelmann EJ, Bart RS, Rogers GS, Rigel DS, Friedman RJ, Levenstein MJ, Gumport SL, Henessey P (1987) Thickness of malignant melanoma: global analysis of related factors. J Dermatol Surg Oncol 13:345–420

    CAS  PubMed  Google Scholar 

  • Kornstein MJ, Brooks JSJ, Elder DE (1983) Immunoperoxidase localisation of lymphocyte subsets in the host response to melanoma and naevi. Cancer Res 43:2749–2753

    CAS  PubMed  Google Scholar 

  • Mascaro JM, Molgo M, Castel T, Castro J (1987) Plasma cells within the infiltrate of primary cutaneous malignant melanoma of the skin. Am J Dermatopathol 9:497–499

    CAS  PubMed  Google Scholar 

  • McGovern VJ, Shaw HM, Milton GW (1983) Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology 7:673–680

    CAS  PubMed  Google Scholar 

  • Naruns PL, Nizze A, Cochran AJ, Lee MB, Morton DL (1986) Recurrence potential of thin primary melanomas. Cancer 57:545–548

    CAS  PubMed  Google Scholar 

  • Ronan SG, Eng AM, Briele HA, Shioura NN, Das Gupta TK (1987) Thin malignant melanomas with regression and metastases. Arch Dermatol 123:1326–1330

    Article  CAS  PubMed  Google Scholar 

  • Sagebiel R (1985) Regression and other factors of prognostic interest in malignant melanoma (editorial). Arch Dermatol 121:1125–1126

    Article  CAS  PubMed  Google Scholar 

  • Schmoeckel C, Bockelbrink A, Bockelbrink H, Braun-Falco O (1983) Low and high risk malignant melanoma. II. Multivariate analyses for a prognostic classification. Eur J Cancer Clin Oncol 19:237–243

    CAS  PubMed  Google Scholar 

  • Shaw HM, McCarthy SW, McCarthy WH, Thompson JF, Milton GW (1989) Thin regressing malignant melanoma: significance of concurrent regional lymph node metastases. Histopathology 15:257–265

    CAS  PubMed  Google Scholar 

  • Simony J, Rossi JF, Shishehian B, Ursule E, Radal M, Pujol H (1991) Characterization of proliferative cells in malignant melanomas and their inflammatory infiltrates. Cancer Detect Prevent 15 3:183–187

    CAS  PubMed  Google Scholar 

  • Slingluff CL, Vollmer RT, Reintgen DS, Seigler HF (1988) Lethal “thin” malignant melanoma. Identifying patients at risk. Ann Surg 208 2:150–161

    PubMed  Google Scholar 

  • Sondergaard K, Schou G (1985) Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. Virchows Arch [A] 406:179–195

    CAS  Google Scholar 

  • Tefany FJ, Barnetson RStC, Halliday GM, McCarthy SW, McCarthy WH (1991) Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. J Invest Dermatol 97:197–202

    Article  CAS  PubMed  Google Scholar 

  • Trau H, Rigel DS, Harris MN, Kopf AW, Friedman RJ, Gumport SL, Bart RS, Robson W, Grier N (1983) Metastases of thin melanomas. Cancer 51:553–556

    CAS  PubMed  Google Scholar 

  • Wanebo HJ, Cooper PH, Ward Hagar R (1985) Thin (less than 1 mm) melanomas of the extremities are biologically favourable lesions not influenced by regression. Ann Surg 201 4:499–504

    CAS  PubMed  Google Scholar 

  • Yonemoto RH, Paladugu RR (1983) Biologic behaviour of thin malignant melanomas with regressive changes. Arch Surg 118:41–44

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cook, M.G. The significance of inflammation and regression in melanoma. Vichows Archiv A Pathol Anat 420, 113–115 (1992). https://doi.org/10.1007/BF02358800

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02358800

Navigation